Elevance Health Q2 Adjusted Earnings Fall, Revenue Rises; Raises Full-Year Adjusted EPS Outlook
() -- Elevance Health (ELV) reported Q2 adjusted earnings Wednesday of $7.45 per diluted share, down from $8.84 a year earlier. Analysts polled by FactSet expected $6.21. Operating revenue for the quarter ended June 30 was $49.83 billion, up from $49.42 billion a year earlier. Analysts surveyed by FactSet expected $48.